Winter Clinical Hawaii Dermatology Conference

Glynis Ablon, MD, FAAD, discusses new aesthetic devices from her presentation at Winter Clinical Hawaii.

James Del Rosso, DO, shares key highlights from his Winter Clinical Hawaii sessions.

Neal Bhatia, MD, gives peals from his JAK inhibitors session at Winter Clinical Hawaii.

Clay J. Cockerell, MD, MBA, kicks off the start of Winter Clinical Hawaii by reviewing challenges and solutions in dermatopathology.

Winter Clinical Hawaii is the place to be according to Glynis Ablon, MD, FAAD, and presenter at the Hawaii conference.

Catch up on coverage from the first day of Winter Clinical Hawaii.

Dermatologists from across the country are getting ready for an engaging week of sessions at Winter Clinical Hawaii.

As Winter Clinical Hawaii begins, find out what presenter Raj Chovatiya enjoys about the meeting.

If you’re attending Winter Clinical Hawaii, here are a few activities to check out on the big island.

The year-long study gives insight to the treatment’s efficacy and safety of durability.

The 2023 Winter Clinical Hawaii Dermatology Conference begins today in Kohala Coast, Hawaii.

Click here to answer this week's poll.

Timber Pharmaceuticals announced a positive end-of-phase 2 meeting with the FDA about TMB-001 in moderate to severe congenital ichthyosis. Timber also revealed when it plans to start a phase 3 trial.

The FDA approved the topical JAK1/JAK2 inhibitor ruxolitinib for the treatment of mild to moderate atopic dermatitis in September 2021.

Treating these patients can be a challenge, but it can also be ‘as easy as pie’ if you follow these tips.

One of the key differences between diagnosing AD in patients with skin of color compared to White skin is erythema.

AAD vice president challenges dermatologists to advocate for their patients and themselves.

Targeting skin care regimens to the individual patient is most likely to yield compliance to a recommended routine.

Resident billing can have huge financial implications on academic institutions. A poster from the Icahn School of Medicine at Mount Sinai aimed to assess new medical coding lectures and a modified note template at Winter Clinical Dermatology Conference.

More trustworthy sources of information, and data, are needed.

As skin manifestations are commonly the first thing spotted with infectious disease, dermatologists are in a great position to counsel patients about prevention.

Studies offer positive outcomes for patients with conditions like hidradenitis suppurativa or psoriasis.

Sunscreen advice, recruiting during the “Great Recession”, and tips for the office led the busy agenda at Winter Clinical Dermatology Conference this weekend.

What new treatments are coming to infectious disease? How can they be prevented and what misconceptions are affecting treatment? Learn about this and more in this video with Ted Rosen, MD.

Ted Rosen, MD, explains the top points of his presentation, "What's Hot and New in Infectious Disease?" from the 2022 Winter Clinical Dermatology Conference.

Treatments awaiting FDA approval could bolster the range of nonsteroids and well-tolerated topicals aimed at combating pediatric cutaneous disorders.

In this video interview, Peter A. Lio, MD, FAAD, expands on his Winter Clinical Dermatology 2022 presentation, "What's Hot and New in Pediatric Dermatology?" He talks the pipeline, black box warnings, and more on atopic dermatitis treatments.

In this video, Peter Lio, MD, FAAD, expands on his presentation at the 19th annual Winter Clinical Dermatology Conference by diving into molluscum contagiousum treatment and the potential of cantharidin 0.7% (VP-102; Verrica).

Several talks expected to focus on the latest treatment updates, as well as some recently published data on COVID-19 symptoms and a commonly-used atopic dermatitis treatment.